Timothy Lewis Tapley

This inventor holds 6 USPTO granted patents and 4 published patent applications and 3 EPO patents. Top assignee: Vertex Pharmaceuticals, Inc.. Active years: 2023-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Timothy Lewis Tapley. Retrieved from https://idiyas.com/inventor/timothy-lewis-tapley

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 6 (Patent Applications = 4)

% Patents Active = 100.0

EPO Patents = 3 (Patent Applications = 5)

Average Co-Inventor Count = 28.5

ph-index = 3

Forward Citations = 14(Granted Patents)

Company Filing History:

6 out of 1,167

Vertex Pharmaceuticals, Inc.

patents

Years Active: 2023-2026

Loading Chart...

6 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12662471 - 7- or 8-hydroxy-isoquinoline and 7- or 8-hydroxy-quinoline derivatives as alpha-1-antitrypsin modulators for treating alpha-1-antitrypsin deficiency (AATD) (2026-06-23),

2. 12624028 - 1H-pyrazolo[4,3-G]isoquinoline and 1H-pyrazolo[4,3-g]quinoline derivatives as alpha-1-antitrypsin modulators for treating alpha-1-antitrypsin deficiency (AATD) (2026-05-12),

3. 12502376 - Pyrano[4,3-b]indole derivatives as alpha-1-antitrypsin modulators for treating alpha-1-antitrypsin deficiency (AATD) (2025-12-23),

4. 12331057 - Modulators of alpha-1 antitrypsin (2025-06-17),

5. 11884672 - Modulators of alpha-1 antitrypsin (2024-01-30),

6. 11623924 - Modulators of alpha-1 antitrypsin (2023-04-11),

Title: The Innovative Contributions of Timothy Lewis Tapley

Introduction: Timothy Lewis Tapley, based in Cardiff, CA, is a notable inventor recognized for his significant contributions to medicine, particularly in the treatment of alpha-1 antitrypsin deficiency (AATD). With three patents to his name, he stands out in the field of pharmaceutical innovation.

Latest Patents: Among his latest inventions, one of the key patents revolves around modulators of alpha-1 antitrypsin. This patent discloses compounds that are highly useful for treating AATD. The invention includes a variety of formulations, such as tautomers, pharmaceutically acceptable salts, deuterated derivatives, and solid forms of these compounds, alongside detailed processes for their synthesis.

Career Highlights: Timothy Tapley is associated with Vertex Pharmaceuticals, Inc., a leading biotech company recognized for its transformative medicines. His work within this organization focuses on advancing treatments that combat serious diseases, leveraging his innovative spirit and technical expertise.

Collaborations: Throughout his career, Timothy has collaborated with talented coworkers including Upul Keerthi Bandarage and Cavan McKeon Bligh. These partnerships highlight the collaborative nature of innovation in the pharmaceutical industry and underscore the importance of teamwork in developing groundbreaking therapies.

Conclusion: Timothy Lewis Tapley's inventive work in the modulation of alpha-1 antitrypsin positions him as a significant figure in the realm of medical innovation. His contributions through patents not only reflect his creativity as an inventor but also his commitment to improving patient outcomes in the healthcare landscape.

Profile summary based on public USPTO records.